By Anna Peiris | Executive Director
Over the past few months, we celebrate a significant achievement: the increased coverage of the role of universities in research and development (R&D) into mainstream media. Our efforts, led by UAEM members across the region, have highlighted the critical issues surrounding pharmaceutical patents, medication pricing, and ethical pharmaceutical practices.
Denmark: Members at Aarhus University achieved outstanding success with the publication of a nationally acclaimed article in Information.dk. Their work critically addressed the high prices of medicine and the impact of pharmaceutical patents on the Danish healthcare system, calling for a reevaluation of current patent practices. Their advocacy highlighted the financial burden on hospitals, the ethical issues surrounding pharmaceutical profit margins, and the necessity for universities to ensure that publicly funded research benefits society. Their proposal to adopt the Equitable Technology Access Framework (ETAF) has sparked widespread debate, positioning Aarhus University at the forefront of advocating for fair and ethical pharmaceutical practices.
Netherlands: Our National Coordinator, Kai Figueras de Vries, collaborated with Wemos to co-author an influential article titled "De overheid subsidieert winsten van farmaceuten en de patiënt heeft het nakijken." The article, which has garnered substantial attention, critiques the current pharmaceutical development system where public funds are used for drug research without guaranteeing patient access to the final products. Highlighting the need for governments to attach conditions to public investments, the article calls for policies that ensure affordable and accessible medications.
France: Our efforts have been focused on addressing critical issues related to medication pricing and accessibility in France, collaborating closely with civil society organizations such as Médecins du Monde. Our national coordinator, Xavier Masset, has played a pivotal role in contributing to the recentlty released white paper, L'Ordonnance de la Société Civile pour une Nouvelle Politque de Médicament, which highlights the ethical responsibility of universities in managing publicly funded research. This work emphasizes the need to ensure that innovations developed through public investment remain affordable and accessible to all. This white paper not only addresses the unsustainable high costs of new medications but also proposes the adoption of the Equitable Technology Access Framework (ETAF) to promote socially responsible licensing practices within universities.
The coverage of our advocacy efforts in university R&D reform has gained significant attention in mainstream media, underscoring the importance of our initiatives. This visibility will support our ongoing efforts to push for fair and ethical pharmaceutical practices, ensuring that publicly funded research benefits society.
Access Accelerated Regional Conference: Finally, at the end of April, we hosted our annual regional conference, Access Accelerated, which brought in members from across the region to enhance their technical knowledge and soft skills. The conference featured engaging sessions on technology transfer modalities, negotiation strategies with Technology Transfer Offices (TTOs), and panel discussions on upcoming focus areas in fair pharmaceutical practices. Workshops facilitated collaborative learning and skill development among participants, fostering innovative campaign avenues and strategies.
We deeply appreciate your continued support for UAEM Europe. Together, we are driving meaningful change to ensure that everyone is able to benefit from health research and innovations.
By Anna Peiris | Executive Director
By Anna Peiris | Executive Director
Project reports on GlobalGiving are posted directly to globalgiving.org by Project Leaders as they are completed, generally every 3-4 months. To protect the integrity of these documents, GlobalGiving does not alter them; therefore you may find some language or formatting issues.
If you donate to this project or have donated to this project, you can receive an email when this project posts a report. You can also subscribe for reports without donating.
Support this important cause by creating a personalized fundraising page.
Start a Fundraiser